There are 381 resources available
21P - Sintilimab in combination with anlotinib in non-small-cell lung cancer patients with uncommon EGFR mutations: A phase II, single-arm, prospective study
Presenter: Kaiyan Chen
Session: Poster Display session
23P - Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trial
Presenter: Ard Veelen
Session: Poster Display session
186P - CIP2A modulates PKM2 dimer-tetramer transition through phosphorylation of serine 287 in non-small cell lung cancer
Presenter: lijun Liang
Session: Poster Display session
188P - Efficacy of SARS-CoV-2 based mRNA vaccines for patients with thoracic malignancies with 6 months follow up: A prospective observational study
Presenter: Urska Janzic
Session: Poster Display session
192P - Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
Presenter: Zachary Moore
Session: Poster Display session
187P - Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: Possible action through leptin gene and its receptor regulation
Presenter: Davoud Jafari-Gharabaghlou
Session: Poster Display session
189P - Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer
Presenter: Ioannis Trontzas
Session: Poster Display session
190P - COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era
Presenter: Rute Fernandes
Session: Poster Display session
191P - Lung cancer care in Europe during COVID-19: Findings from a global survey of patient experience
Presenter: Jackie Fenemore
Session: Poster Display session
185P - Clinicopathological characterization of NGS detected mutations in lung cancers: A single center experience
Presenter: Julia Walter
Session: Poster Display session